The global microfluidics market size reached USD 20.14 Billion in 2021 and is expected to register a revenue CAGR of 16.1% during the forecast period, according to latest analysis by Emergen Research. Rapid technological advancements in the field of microfluidics such as Point-of-Care Testing (PoCT) and In-Vitro Diagnostics (IVD), significant investments in research development activities, rising demand for microfluidic platforms for early disease detection and pathogen identification, as well as increasing applications of microfluidic platforms in various healthcare industries are factors driving market revenue growth.
The latest market intelligence report broadly assesses this ever-evolving business sphere and simultaneously elaborates on the production and consumption aspects. The study analyzes numerous indispensable factors, including market growth drivers, opportunities, restraints, and challenges, which are presumed to impact the global market growth in the next few years. The SWOT and Porter’s Five Forces analyses performed in this report assist the reader in understanding the competitive hierarchy of the Microfluidics market
To get a sample copy of the global Graphene market report, visit @ https://www.emergenresearch.com/request-sample/35
The competitive landscape and company profiles included in the report underscore the major players participating in the global Microfluidics market and strategic initiatives undertaken by them for business expansion. The company profiles include information assessed by employing analytical tools like SWOT analysis of established and emerging players. A detailed supply chain and value chain analysis have also been entailed in the report, with a broad analysis of the market’s vendor landscape.
Leading Players Profiled in the Report Are:
UFluidix, Quidel Corporation, biosurfit SA, Abbott, Illumina, Inc., Abaxis, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., and Becton Dickinson and Company (BD).
Emergen Research has segmented the global microfluidics market based on material type, application, component, and region:
Material Type Outlook (Revenue, USD Billion; 2019-2030)
Application Outlook (Revenue, USD Billion; 2019-2030)
Point-of-Care Testing (POCT) Diagnostics
Drug Delivery Systems
Pharmaceutical and Biotechnology Research
Components Outlook (Revenue, USD Billion; 2019-2030)
To get the report at an incredible discount, visit @ https://www.emergenresearch.com/request-discount/35
Some Key Highlights from the Report
The polymer segment accounted for a significantly robust revenue share in 2021. Increasing demand from the packaging industry due to low cost and well-maintained fabrication techniques, for which polymers are favored is a key factor driving revenue growth of this segment. Poly(dimethylsiloxane) (PDMS) is a preferred choice from among these materials and has been widely used in microfluidics for fast and quick prototyping reasons, as it is easy to make and adheres tightly to glass and PDMS substrates with greater and improved optical transparency and elastomeric characteristics. Two perfluorinated polymers are utilized to construct microfluidic devices and structures, perfluoroalkoxy (Teflon PFA) and fluorinated ethylenepropylene (Teflon FEP), as these maintain their elastomeric and inertness, which makes them suitable for microfluidic platforms.
The microfluidic chip segment accounted for a significantly large revenue share in 2021. Microfluidic chips ae based on miniaturization technology to enable entire biochemical processes including reagent loading, reaction, separation, and detection, to be performed on a microchip. Densely interconnected microfluidic chips are small, portable, and only require a few consumables for early disease detection. Microfluidic technologies such as LOC technology, Three-Dimensional (3D) cell culture, organs-on-a-chip, and droplet techniques have advanced rapidly into various fields. Microfluidic chips, in combination with various detection techniques, are ideal for high-throughput drug testing, detection, and mechanistic research. These chips can be utilized in nanoparticle synthesis, drug encapsulation, delivery, targeting, cell analysis, and cell culture, either alone or in combination with other devices.
Asia Pacific market accounted for a moderate revenue share in 2021. Rising demand from biomedical and pharmaceutical sectors and in point-of-care testing, increased prevalence of chronic diseases, and increasing investments in RD activities, particularly in Singapore, are key factors driving market revenue growth. For instance, a team of researchers from the University of Bristol has developed a novel low-cost and open-source 3D printing process for producing microfluidic devices. The process named Elsewhere, Developed by the Singapore University of Technology and Design, enables 3D printing of microfluidic devices integrated with fluid handling and functional components. Among the countries in Asia Pacific, China, Japan, and India account for majority revenue share contribution to the market in the region and the trend is expected to continue over the forecast period.
Key Questions Addressed in the Report:
Who are the leading players in the Microfluidics industry?
Which region is expected to dominate the market in the coming years?
What are the key applications of Microfluidics?
Which segment is expected to garner traction during the coming years?
What are the key strategies adopted by leading players in the market?
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
In conclusion, the report provides a qualitative and quantitative analysis of the Global Microfluidics market, including the global and regional analysis of the market. The study covers critical information and factual data about the Microfluidics market industry, along with an in-depth statistical analysis of the market drivers, limitations, growth prospects, opportunities, and threats. On the basis of the current market scope, the report provides an extensive analysis of how the Microfluidics market is expected to fare in the forecast timeline. The report utilizes advanced analytical tools to offer an estimation of the outlook of the global state of the Microfluidics market industry.
Request a customized copy of report @ https://www.emergenresearch.com/request-for-customization/35
Thank you for reading our report. For further details or to inquire about the customization of the report, please reach out to our team. We will offer you the report as per your requirements.
Take a Look at our Related Reports:
Radiofrequency-Based Devices Market https://www.digitaljournal.com/pr/radiofrequency-based-devices-market-size-worth-usd-9595-9-million-in-2028-increasing-prevalence-of-chronic-diseases-and-growing-demand-for-minimally-invasive-procedures-are-key-factors-driving-reven
Access Control Market https://www.digitaljournal.com/pr/access-control-market-recent-industry-developments-and-growth-strategies-adopted-by-key-players-with-revenue-insights-and-forecast-by-2030-states-the-report-by-emergen-research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Visit for More Insights: https://www.emergenresearch.com/insights
Read Press Release@ https://www.emergenresearch.com/press-release/global-microfluidics-market